Dr. Peter McCullough’s foundation has recently sounded the alarm over a new U.S. policy which will result in biological laboratories with very little oversight being able to operate with the U.S., a similar phenomenon as was seen in the Wuhan Lab in China which released Covid.
The policy, ‘United States Government Policy for Oversight of Dual Use Research of Concern and Pathogens with Enhanced Pandemic Potential’ was published in May and outlines protocols and requirement changes in the relationship between biological laboratories and the U.S. regulators over such labs. Overall the policy which focuses on ‘oversight’ weakens the oversight, according to McCullough.
New U.S. Policy Unleashes Unchecked Bio-Labs, Paving the Way for the Next Lab-Created Pandemic
— McCullough Foundation (@McCulloughFund) September 22, 2024
This policy reads like a dream for National Institutes of Health (NIAID, BARDA) and Department of Defense (DARPA) funded laboratories. There is very little reporting required, no… pic.twitter.com/ADwGNti0tc
The McCullough Foundation pointed out that much of the funding of these dangerous pathogens comes from the private sector, so reporting, and thus decent oversight, will be optional.
“For labs funded by foundations such as Gates, Wellcome Trust, Rockefeller and many more, government funding is not a risk, so reporting becomes optional,” the McCullough Foundation said in a social media post on Sunday.
Dangerous pathogens such as Covid could be developed in order to develop countermeasures to it. There is great irony in a lab developing a cure to a disease that only that lab has. It is a textbook case of problem, reaction, solution.
“It describes the development of ‘pathogens with enhanced pandemic potential’ as a goal of covered research. For example, SARS-CoV-2 could have been dually developed as a biological threat to populations but also the development of counter-measures including monoclonal antibodies and vaccines which would be considered benefits to the world,” the McCullough Foundation said in a social media post on Sunday.
Alarmingly, this policy will allow for a possible release of a yet-known ‘Disease X‘ pandemic pathogen, according to The McCullough Foundation.
“As a result, we can expect the next Disease X pandemic(s) to have laboratory origins supported by this policy,” the McCullough Foundation said in a social media post on Sunday.
Dr. McCullough himself commented on the policy on his Substack.
“…a 31 page document that outlines an oversight plan for the development of biological threats (viruses, bacteria, fungi, toxins) that can be of dual use to humanity—for benefit or harm. The paragraphs of this guidance reads like a dream for National Institutes of Health (NIAID, BARDA) and Department of Defense (DARPA) funded laboratories,” McCullough said on his Substack on Sunday. “There is very little reporting required, no comprehensive inventories, and recommended but not required bio-security (hoods, reverse ventilation, protection of workers, etc): ‘In such cases, agents affecting humans that are recommended to be handled at Biosafety Level 3 (BSL-3) or Biosafety Level 4 (BSL-4) per the BMBL guidance are subject to this Policy.’ No mandate or audits are mentioned.”
